Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Healthcare heavyweight IPO
Burns-to-ulcers treatment group ConvaTec is to float on London’s Main Market in the next month. It hopes to raise $1.8bn to help reduce debt. The Reading-based group could become a candidate for the FTSE 250 or even FTSE 100. Bristol-Myers Squibb (BMY:NYSE) sold the business to private equity for $4.1bn in 2008. (DC)